Gracell Biotechnologies Buy Hold or Sell Recommendation
| GRCLDelisted Stock | USD 4.02 0.26 6.07% |
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding Gracell Biotechnologies is 'Not Rated'. The recommendation algorithm takes into account all of Gracell Biotechnologies' available fundamental, technical, and predictive indicators you will find on this site.
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. Note, we conduct extensive research on individual companies such as Gracell and provide practical buy, sell, or hold advice based on investors' constraints. Gracell Biotechnologies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.
Gracell |
Execute Gracell Biotechnologies Buy or Sell Advice
The Gracell recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Gracell Biotechnologies. Macroaxis does not own or have any residual interests in Gracell Biotechnologies or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Gracell Biotechnologies' advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Not Rated
Gracell Biotechnologies Trading Alerts and Improvement Suggestions
| Gracell Biotechnologies is not yet fully synchronised with the market data | |
| Gracell Biotechnologies has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (496.98 M) with profit before overhead, payroll, taxes, and interest of 366 K. | |
| Gracell Biotechnologies currently holds about 1.71 B in cash with (482.65 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 25.28, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Roughly 63.0% of the company shares are owned by institutional investors |
Gracell Biotechnologies Returns Distribution Density
The distribution of Gracell Biotechnologies' historical returns is an attempt to chart the uncertainty of Gracell Biotechnologies' future price movements. The chart of the probability distribution of Gracell Biotechnologies daily returns describes the distribution of returns around its average expected value. We use Gracell Biotechnologies price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Gracell Biotechnologies returns is essential to provide solid investment advice for Gracell Biotechnologies.
| Mean Return | 1.43 | Value At Risk | -6.25 | Potential Upside | 16.34 | Standard Deviation | 8.36 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Gracell Biotechnologies historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Gracell Biotechnologies Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Gracell . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Gracell Biotechnologies Buy or Sell Advice
When is the right time to buy or sell Gracell Biotechnologies? Buying financial instruments such as Gracell Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Gracell Biotechnologies in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Global Macro ETFs Thematic Idea Now
Global Macro ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Global Macro ETFs theme has 26 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Global Macro ETFs Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Consideration for investing in Gracell Stock
If you are still planning to invest in Gracell Biotechnologies check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Gracell Biotechnologies' history and understand the potential risks before investing.
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Stocks Directory Find actively traded stocks across global markets | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device |